Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Blood

• Publication date

  2011-03-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2010-07-295501PMID 21079152PMCID PMC3062298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

  2010cited by this paper
• Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.

  2010cited by this paper
• Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

  2010cited by this paper
• Genetic and Pathogenetic Aspects of Noonan Syndrome and Related Disorders

  2009cited by this paper
• FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.

  2009cited by this paper
• NRAS mutation causes a human autoimmune lymphoproliferative syndrome

  2007cited by this paper
• Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib

  2007cited by this paper
• Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations.

  2007cited by this paper
• A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.

  2006cited by this paper
• Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

  2004cited by this paper
• Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.

  2004cited by this paper
• Ras processing as a therapeutic target in hematologic malignancies.

  2002influential reference
• Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

  2002cited by this paper
• Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.

  1999cited by this paper
• Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

  1999cited by this paper
• The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.

  1997influential reference
• Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

  1997cited by this paper
• K-ras modulates the cell cycle via both positive and negative regulatory pathways

  1997cited by this paper
• Regulation of the cell cycle machinery by oncogenic ras.

  1996cited by this paper
• Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

  1996cited by this paper
• Clinical, immunological, and pathological consequences of Fas-deficient conditions.

  1996cited by this paper
• Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

  1995cited by this paper
• Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

  1995cited by this paper
• A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

  1992cited by this paper
• Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors.

  1991cited by this paper
• ras genes.

  1987cited by this paper
• Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

  year unknowncited by this paper

• A Clinical Decision Framework for Redox-Adapted, EMT-High Cancers: From Ferroptosis Resistance to Precision Therapeutic Stratification

  2026cites this paper
• Somatic genomics as a discovery engine for biomedicine.

  2026cites this paper
• Immune dysregulation diseases caused by somatic mutations

  2026cites this paper
• Incomplete penetrance in inborn errors of immunity: A skeleton in the closet—The sequel

  2025cites this paper
• Abnormal immunoglobulin expression and B-cell follicle organization in inborn errors of immunity/primary immunodeficiency.

  2025cites this paper
• Treatment of RAS-associated leukoproliferative disease (RALD) and Rosai-Dorfman disease in a patient with KRAS mutation

  2025cites this paper
• Early-onset systemic lupus erythematosus in a patient with an inborn error of immunity caused by a NRAS mutation and treated with telitacicept

  2025cites this paper
• Identifying genetic errors of immunity due to mosaicism.

  2025cites this paper
• The Fas-mediated apoptosis assay: From concept to clinical application.

  2025cites this paper
• Somatic mutations associate with clonal expansion of CD8+ T cells

  2024cites this paper
• Mechanism and target treatment of primary immunodeficiency diseases with systemic lupus erythematosus‐like phenotype

  2024cites this paper
• Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations

  2024cites this paper
• RAS-associated Autoimmune Leukoproliferative Disease (RALD-KRAS) Consistent with the Clinical Diagnosis of Rosai-Dorfman Disease: A 15-year Follow-up

  2024cites this paper
• Monoallelic KRAS (G13C) mutation triggers dysregulated expansion in induced pluripotent stem cell-derived hematopoietic progenitor cells

  2024cites this paper
• Mendelian Causes of Autoimmunity: the Lupus Phenotype

  2024cites this paper
• KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia.

  2024cites this paper
• Probable Autoimmune Lymphoproliferative Syndrome with Monogenic Lupus Due to KRAS Mutation

  2024cites this paper
• Somatic mosaicism in genetic errors of immunity.

  2024cites this paper
• Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus – focus on juvenile-onset systemic lupus erythematosus

  2024cites this paper
• NGS data analysis for molecular diagnosis of Inborn Errors of Immunity.

  2024cites this paper
• Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

  2024cites this paper
• Somatic mutations in autoinflammatory and autoimmune disease

  2024cites this paper
• Inborn Errors of Immunity and Cytokine Storm Syndromes.

  2024cites this paper
• Sequential mosaic variants in KRAS and STAT5B associated with a mixed phenotype of two acquired errors of immunity

  2024cites this paper
• Genetic Testing in Patients with Autoimmune Lymphoproliferative Syndrome: Experience of 802 Patients at Cincinnati Children’s Hospital Medical Center

  2024cites this paper
• A Race to the Finish.

  2023cites this paper
• Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy.

  2023cites this paper
• Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.

  2023cites this paper
• Inborn Errors of Immunity and Autoimmune Disease.

  2023cites this paper
• Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives.

  2023cites this paper
• Hyper‐IgE syndrome presenting with early life craniosynostosis in monozygotic twin sisters

  2023cites this paper
• Histopathological and molecular findings in a patient with Ras-associated autoimmune leukoproliferative disorder

  2022cites this paper
• ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies

  2022cites this paper
• Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

  2022cites this paper
• EAHP 2020 workshop proceedings, pediatric myeloid neoplasms

  2022cites this paper
• High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls

  2022cites this paper
• Nem malignus, nem infectiosus lymphoproliferatio: kihívások az autoimmun lymphoproliferativ szindróma diagnosztikájában és kezelésében

  2022cites this paper
• Autoimmune Lymphoproliferative Syndrome

  2021cites this paper
• Current Treatment of Juvenile Myelomonocytic Leukemia

  2021cites this paper
• Whole Exome Sequencing for the Identification of Mutations in CD8+ T-Cells.

  2021cites this paper
• Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome

  2021cites this paper
• Phenocopies of inborn errors of immunity

  2021cites this paper
• Genetic Mosaicism as a Cause of Inborn Errors of Immunity

  2021cites this paper
• Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity

  2021cites this paper
• Pediatric Neoplasms Presenting with Monocytosis

  2021cites this paper
• Idiopathic splenomegaly in childhood and the spectrum of RAS-associated lymphoproliferative disease: a case report

  2021cites this paper
• Somatic Mutations in Rheumatologic Diseases: VEXAS Syndrome and Beyond.

  2021cites this paper
• CD8+ cell somatic mutations in multiple sclerosis patients and controls—Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies

  2021cites this paper
• Mosaicism in rare disease

  2021cites this paper
• Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management

  2021cites this paper
• Phenocopies of Primary Immunodeficiency Diseases

  2021cites this paper
• Diseases of Immune Dysregulation

  2021cites this paper
• Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD)

  2020cites this paper
• Phenocopies of inborn errors of immunity

  2020cites this paper
• Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD)

  2020cites this paper
• After 95 years, it's time to eRASe JMML.

  2020cites this paper
• Evans Syndrome in the Adolescent Female

  2020cites this paper
• Autoimmune Hemolytic Anemia in Adolescent Females

  2020cites this paper
• Autoimmune Lymphoproliferative Syndrome

  2020cites this paper
• Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature

  2020cites this paper
• Incomplete penetrance in primary immunodeficiency: a skeleton in the closet

  2020cites this paper
• RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children

  2019cites this paper
• Superficial and Deep Cutaneous Involvement by RAS-Associated Autoimmunne Leukoproliferative Disease (RALD Cutis): A Histologic Mimicker of Histiocytoid Sweet Syndrome.

  2019cites this paper
• Juvenile myelomonocytic leukemia: who's the driver at the wheel?

  2019cites this paper
• Pulmonary Manifestations of Genetic Disorders of Immune Regulation

  2019cites this paper
• Autoimmune Lymphoproliferative Syndrome: An Overview.

  2019cites this paper
• Somatic mutations in autoimmunity

  2019cites this paper
• Primary Immunodeficiencies and Cytokine Storm Syndromes

  2019cites this paper
• An updated review on phenocopies of primary immunodeficiency diseases

  2019cites this paper
• Somatic Variants: New Kids on the Block in Human Immunogenetics.

  2019cites this paper
• The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy.

  2019cites this paper
• Somatic mutations and T-cell clonality in patients with immunodeficiency

  2019cites this paper
• Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation

  2019cites this paper
• Primary immunodeficiencies: novel genes and unusual presentations.

  2019cites this paper
• Abstracts from the Immunodeficiency Canada—6th SCID Symposium, Halifax, NS, 13 September 2018

  2018cites this paper
• Cutaneous involvement in an 8‐year‐old boy with Ras‐associated autoimmune leucoproliferative disorder (RALD)

  2018cites this paper
• Molecular Classification of Primary Immunodeficiencies of T Lymphocytes.

  2018cites this paper
• Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.

  2018cites this paper
• Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond

  2018cites this paper
• Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders

  2018cites this paper
• Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity

  2018cites this paper
• Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report

  2018cites this paper
• Weekly Rituximab Followed by Monthly Rituximab Treatment for Autoimmune Disease Associated With RAS-associated Autoimmune Leukoproliferative Disease.

  2018cites this paper
• Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides

  2018cites this paper
• Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension

  2018cites this paper
• FAS and RAS related Apoptosis defects: From autoimmunity to leukemia

  2018cites this paper
• Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation

  2018cites this paper
• Systemic lupus erythematosus in a patient with Noonan syndrome‐like disorder with loose anagen hair 1: More than a chance association

  2018cites this paper
• Evans Syndrome: Background, Clinical Presentation, Pathophysiology, and Management

  2018cites this paper
• AWARD NUMBER: W81XWH-14-1-0609 TITLE: Studying the Immunomodulatory Effects of Small Molecule Ras-Inhibitors in Animal Models of Rheumatoid Arthritis

  2017cites this paper
• A novel class of somatic mutations in blood detected preferentially in CD8 + cells

  2017cites this paper
• Turning the tide in myelodysplastic/myeloproliferative neoplasms

  2017cites this paper
• Genetic Disorders of Immune Regulation

  2017cites this paper
• Systemic lupus erythematosus associated with RASopathy

  2017cites this paper
• Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders

  2017cites this paper
• Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome

  2017cites this paper
• Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network

  2017cites this paper
• In Vitro Evaluation of the Apoptosis Function in Human Activated T Cells.

  2017cites this paper
• Next-Generation Sequencing Based Clinical Molecular Diagnosis of Primary Immunodeficiency Diseases

  2017cites this paper
• Molecular genetics and cellular events of K-Ras-driven tumorigenesis

  2017cites this paper